Because of the well-defined, stepwise progression of esophageal, researchers jumped on it as a way to test the ability of berries – the healthiest fruits – to reverse the progression of cancer. A randomized phase 2 clinical trial of strawberries for patients with precancerous lesions of the esophagus was undertaken. Six months of eating the equivalent of over a pound of fresh strawberries a day, and the progression of disease was reversed in 80 percent of the high dose strawberry treatment.
At the beginning of the study, no subjects had a normal esophagus. They either had mild or moderate precancerous disease. But by the end of the study most lesions either regressed from moderate to mild, or disappeared completely. If you watch the above video you can see some representative before and after pictures of the lesions literally disappearing. By the end of the study half of those on the high dose of strawberries walked away disease free.
This landmark study is one of the most important papers I’ve seen recently. Why isn’t this headline news? If there was instead some new drug that reversed cancer progression, you can bet it would be all over the place. But who’s going to profit from revelations about berries? Other than, of course, the millions of people at risk for this devastating cancer.
The findings were heralded as groundbreaking in an editorial in the journal of the American Association for Cancer research. Given that it was written by a pair of pharmacy professors, though, they of course concluded “that the active components and molecular targets responsible for the efficacy of strawberries must be identified.” Instead of just eating strawberries they suggested that Big Pharma should try to make a strawberry-derived drug…
Could it just be the vitamin C? If so, kiwis would beat strawberries.